Radiocontrast reactions.
Lieberman
P
P
Siegle
R L
RL
Treadwell
G
G
D000707:Anaphylaxis / Q000139:chemically induced; D000937:Antigen-Antibody Reactions; D001491:Basophils / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects; D003167:Complement Activation / Q000187:drug effects; D003287:Contrast Media / Q000009:adverse effects* / Q000145:classification / Q000494:pharmacology; D004342:Drug Hypersensitivity / Q000150:complications / Q000209:etiology* / Q000276:immunology / Q000517:prevention & control; D005174:Factor XII / Q000502:physiology; D006632:Histamine / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D008407:Mast Cells / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use; D012306:Risk
D003287:Contrast Media; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D007073:Immunoglobulin E; D006632:Histamine; D005174:Factor XII; D011241:Prednisone